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Abstract  
Hypofunctioning of the N-methyl-D-aspartate (NMDA)-receptor (NMDA-R) has been 
prominently implicated in the pathophysiology of schizophrenia (ScZ). The current study 
tested the effects of ketamine, a dissociative anesthetic and NMDA-R antagonist, on resting-
state activity recorded with magnetoencephalography (MEG) in healthy volunteers. In a 
single-blind cross-over design, each participant (n = 12) received, on two different sessions, a 
subanesthetic dose of S-ketamine (0.006 mg/Kg) and saline injection. MEG-data were 
analyzed at sensor- and source- level in the beta (13-30 Hz) and gamma (30-90 Hz) frequency 
ranges. In addition, connectivity analysis at source-level was performed using transfer entropy 
(TE). Ketamine increased gamma-power while beta-band activity was decreased. Specifically, 
elevated 30-90 Hz activity was pronounced in subcortical (thalamus and hippocampus) and 
cortical (frontal and temporal cortex) regions, whilst reductions in beta-band power were 
localized to the precuneus, cerebellum, anterior cingulate, temporal and visual cortex. TE 
analysis demonstrated increased information transfer in a thalamo-cortical network after 
ketamine administration. The findings are consistent with the pronounced dysregulation of 
high-frequency oscillations following the inhibition of NMDA-R in animal models of ScZ as 
well as with evidence from EEG-data in ScZ-patients and increased functional connectivity 
during early illness stages. Moreover, our data highlight the potential contribution of thalamo-
cortical connectivity patterns towards ketamine-induced neuronal dysregulation, which may 
be relevant for the understanding of schizophrenia as a disorder of disinhibition of neural 
circuits. 
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Clinical Trial registration: 
Trial name: EudraCT 
Trial registry URL: https://eudract.ema.europa.eu/ 
Trial registration number: EudraCT number 2011-002937-21 
Field Code Changed
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1) Introduction   
Schizophrenia (ScZ) is a debilitating psychiatric condition characterized by positive (e.g., 
hallucinations and delusions) and negative symptoms (e.g., flat affect), as well as cognitive 
deficits. Recent evidence suggests that a deficit in excitation/inhibition (E/I) balance 
parameters may constitute a pathophysiological mechanism that could underlie impairments 
in cognition and certain clinical symptoms (1). This is because during normal brain 
functioning, the generation of coherently organized large-scale networks is critically 
dependent upon the activity of gamma-aminobutyric acid (GABA) inhibitory interneurons 
expressing the calcium (Ca2+) binding protein parvalbumin (PV) (2) and glutamatergic 
activation of PV interneurons (3), leading to rhythmic fluctuations of neuronal excitability at 
low  and high-frequency ranges (4).  
Specifically, NMDA-receptors number and functionality have been critically implicated 
in the pathophysiology of ScZ (5, 6) and abnormalities in glutamatergic transmission are a 
candidate mechanism for disturbed high frequency oscillations in the disorder. In-vivo and in-
vitro electrophysiological studies using NMDA-R antagonists have revealed an increase of 
spontaneous power at both low (30-60 Hz) and high (60-130 Hz) gamma-band ranges as well 
as at ripple frequencies (130-200 Hz) (7). In contrast, oscillations at lower-frequencies, such 
as in the theta-band, are reduced (7). Only a small number of studies have reported no effects 
(8) or a decrease (9). Different gamma-band frequencies, however, are not always equally 
modulated by ketamine and regional differences have been reported in some studies (8).  
In the current study, we investigated the impact of ketamine on resting-state activity in 
MEG-recordings in healthy volunteers to establish links between pre-clinical research and 
findings from EEG/MEG-recordings in ScZ-patients. Recent evidence from spontaneous EEG 
recordings in ScZ-patients has reported increased spontaneous high-frequency activity in ScZ 
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(10, 11) although this has not been confirmed in all studies (10). In addition, several studies 
with functional magnetic resonance imaging (fMRI) indicated increased connectivity in large-
scale networks following ketamine administration (12) which parallels findings in participants 
at-risk for psychosis and patients with first-episode ScZ (13).  
Together with findings of elevated glutamate levels in early-stage ScZ (14), these 
findings raise the possibility that NMDA-hypofunctioning may underlie certain neuronal 
signatures of the disorder, highlighting the need to investigate the effects of Ketamine on 
gamma-band oscillations in healthy volunteers. However, in humans, only preliminary 
evidence exists on increased gamma-band power at rest following ketamine-administration at 
subanesthetic dosages (15).  
 
2) Methods and Materials 
2.1) Participants 
Twelve participants (two females) with a mean age of 29.6 years (range: 27-39) were 
recruited and the structured Clinical Interview for DSM-IV (SCID-II) (16) was administered. 
If criteria were met for a past or present Axis I or II diagnosis or endorsed a family history of 
psychosis, the participant was excluded from the study. The medical screening consisted of a 
physical examination along with regular ECG, vital signs, blood tests, drug screening and 
psychological testing (see Supplementary Methods for a list of the tests adopted). The study 
was carried out according to the Declaration of Helsinki and approved by the ethical 
committees of the Goethe University Frankfurt. After complete description of the study to the 
participants, written informed consent was obtained.  
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2.4) Experimental procedure 
This study follows a single-blind, randomized, placebo-controlled, crossover design. At 
the beginning of the experimental session, a bolus of 10 mg S-ketamine (drug condition) or 10 
ml of NaCl 0.9% (placebo condition) was injected. This was followed by continuous 
intravenous infusion at 0.006 mg S-ketamine per Kg body weight per minute or NaCl 0.9%, 
respectively. We recorded eight minutes (four minutes with eyes open and four minutes with 
eyes closed) of resting-state activity during the continuous drug (ketamine or placebo) 
infusion. Only the eyes closed condition will be reported. Resting state activity was recorded 
circa 45 minutes after bolus injection, time in which participants performed a visual task (data 
not reported here). Following the MEG-recording, participants were examined using the 
Positive and Negative Syndrome Scale (PANSS) (17) with the addition of the 
‘disorganization’ factor (18). For each subject the placebo and ketamine conditions were 
completed between two and four weeks apart.  
 
2.5) Anatomical MRI data acquisition 
Prior to the MEG-measurement, a high-resolution anatomical MRI scan was acquired for each 
participant using a 3D magnetization-prepared rapid-acquisition gradient echo sequence (160 
slices; voxel size: 1x1x1 mm; FOV: 256 mm; TR: 2300 ms; TE: 3.93 ms). Scanning was 
performed using a 3-Tesla Siemens Trio scanner. 
 
2.6) MEG-data acquisition 
MEG data were acquired using a 275-sensors whole-head system (Omega 2005, VSM 
MedTech Ltd, BC, Canada) at a sampling rate of 600 Hz in a synthetic third order axial 
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gradiometer configuration. Data were band-passed filtered offline between 1-150 Hz, and 
participants’ head movements were monitored before and after each recording using coils 
placed on the nasion and 1 cm anterior of the tragus of the left and right ear. Head movements 
were monitored before and after the recording. Recordings with movements larger than 5 mm 
were excluded from the analysis. 
 
2.7) MEG data processing and analysis  
Preprocessing and analysis of the MEG data was performed with the open source Matlab 
toolbox “FieldTrip” (19). The continuous recording was divided in segments of 2 seconds, 
each constituting a trial. Trials containing eye blinks or artifacts due to muscle activity or 
sensors (SQUIDs) jumps were discarded using automatic artifact rejection routines. Data were 
processed and statistically analyzed both at the sensor- and at the source-level. In addition, to 
investigate the effects of ketamine on the interactions between “drug-reactive” sources, we 
quantified changes in information transfer by measuring transfer entropy (TE) (20), as 
implemented in the TRENTOOL toolbox (21, 22).  
 
2.7.1) Sensor- and source- level analysis 
Sensor-level beta (13-30 Hz) and gamma (30-90 Hz) frequency activity was estimated using 
Morlet-wavelet convolution (5 cycles per wavelet). A non-parametric dependent samples t-
test based on a permutation approach (1500 permutations) (23) was used to test differences 
between the placebo and ketamine conditions on all MEG sensors. To minimize the influence 
of differences in the distance between MEG-sensors and head position on amplitude 
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fluctuations, data was normalized both for high and low frequency analysis by dividing the 
amplitude of each frequency by the sum of the amplitudes of all frequencies.  
Power-spectra were source-localized using a Dynamical Imaging of Coherent Sources 
(DICS) frequency beamformer (24). Single-subject source power estimates were normalized 
to the template brain of the Montreal Neurological Institute (MNI) using SPM8 
(http://www.fil.ion.ucl.ac.uk/spm). Source data were statistically analyzed using cluster-based 
permutations (1500 permutations). 
 
2.7.2) Transfer Entropy (TE) 
Source-level functional connectivity between regions showing spectral changes after ketamine 
administration (see Results section below) was estimated using TE (25, 26). TE estimates the 
amount of information communicated from a source to a target process. This is achieved by 
quantifying how much information in the future of the target process is only predictable when 
knowing the past states of the source process. In this sense, TE can be seen as a more general, 
information theoretic version of Wiener-Granger causality (see Supplementary information 
for details on TE analysis). In the first step of our analysis, we extracted the time-course (i.e., 
virtual channels) of all sources showing ketamine-reactivity in the beta and gamma bands. We 
then assessed the global, drug-driven, change in TE between all sources through averaging TE 
values across all links per participant and conditions. To localize these changes across the 
links post-hoc, a one-sided permutation test for each link was performed and the alpha level 
was corrected for multiple comparisons using Bonferroni correction. Given the number of 
sources (n = 16) and the number of potential interactions for each source (n = 15), p was set to 
0.05 / 240 (2.08 * 10-4). In addition, we investigated TE-changes separately for 
interactions between sources in the beta- and gamma-frequency ranges as well as 
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between sources that were active in two different spectral bands (for this additional 
analysis, if no connectivity survived the Bonferroni-corrected threshold of 2.08 * 10-4, we 
adopted a more liberal threshold of p < 0.0005 uncorrected). 
 
3) Results 
3.1) PANSS-Data 
Ketamine lead to a statistically significant increase in all of the six PANSS subscales (see 
Figure 1 and Table S1).  
 
3.2) Sensors- and source- level MEG results 
After artifact rejection, 77 trials (SD = 21) remained in the placebo and 84 trials (SD = 12) in 
the ketamine condition. Ketamine administration caused an increase in gamma-band (30-90 
Hz) power over frontal, parietal and temporal MEG sensors (see Figure 2). Similar to the 
sensor-level results, source-analysis demonstrated an increase in the gamma-band frequency 
range following ketamine administration in a number of cortical and subcortical regions. 30-
90 Hz power was most prominently increased in the right hippocampus and right/left thalami, 
followed by cortical structures, such as the left fusiform gyrus, right medio frontal cortex, left 
frontal pole, left superior frontal gyrus, left superior temporal gyrus and left middle temporal 
gyrus (see Figure 3 and Table S2).  
In contrast to gamma-band power, beta-band (13-30 Hz) activity was reduced after 
ketamine administration in particular over central MEG sensors. At the source-level, beta-
band decreases were localized to the cerebellum, left/right precunei, right middle temporal 
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gyrus, left anterior cingulate cortex, right inferior temporal gyrus and visual cortex (see Figure 
3 and Table S3).  
 
3.3) Correlation between MEG-source activity and PANNS 
Source-power in two anatomical regions showing the strongest ketamine effect in the gamma-
band range (right hippocampus and right thalamus) were correlated to the PANSS subscales 
using a non-parametrical Spearman correlation. Results showed a negative correlation 
between right hippocampus power after ketamine injection and PANSS Positive scale (rs(12) 
= -0.70, p = .011).  
 
3.4) Transfer entropy results 
Ketamine administration caused an increase in the average TE-values (see Figure 5A for 
uncorrected effects). Connections that survived multiple comparisons correction were 
localized to links from left middle temporal gyrus (MTG-L) to right inferior temporal gyrus 
(ITG-R); ITG-R to the left Thalamus (Th-L, ); Th-L to right visual cortex (Visual Cortex-R); 
Visual Cortex-R to right precuneus (Prec-R); Prec-R to Th-L (Figure 5B). Connections with 
significant increases in information transfer were found for source pairs comprising three of 
four possible types: between sources with ketamine-induced changes in the beta-band, 
between sources with changes in the gamma band, and from sources with changes in the 
gamma band to sources with changes in the beta band. Changes in TE values for the 
remaining type, from sources with changes in the beta band to sources with changes in the 
gamma band were found at slightly less conservative thresholds of p < 0.0005 (Figure 5D). 
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For the purpose of comparison we also present the other connection types at this threshold 
(Figure 5C-E).   
  
4) Discussion 
There is increasing evidence suggesting that core features of ScZ may be the consequence of 
hypofunctioning of NMDA-receptors (5). In the current study, we investigated the effects of 
ketamine, a noncompetitive antagonist of the NMDA-R, on resting-state MEG-activity in 
healthy volunteers, to establish whether changes in amplitude fluctuations and connectivity 
patterns following ketamine administration allow links to the pathophysiology of ScZ. 
Currently, only preliminary evidence exists on the effects of ketamine in humans on 
spontaneous beta/gamma-band activity (15). Our findings of pronounced increases in gamma-
band power and increased functional connectivity are in agreement with extensive pre-clinical 
data on the effects of ketamine on neural oscillations (27-32). Moreover, there are similarities 
with evidence from EEG and fMRI-recordings in ScZ (13, 33), which together have 
potentially important implications for the understanding of ScZ as a disorder involving 
fundamentally a disinhibition of cortico-subcortical circuits.  
 
Ketamine Effects on High-frequency activity: Potential neurophysiological mechanisms 
The spectra during resting-state activity corresponded to the usual 1/f distribution both in the 
placebo and in the ketamine condition. The contrast between ketamine-induced spectral 
activity and the placebo condition, however, suggests an upregulation of high-frequency 
activity with a peak ~ 60 Hz (Figure 4). The frequency as well as the magnitude of this effect 
are comparable to visually-induced activity that has been described in recent MEG-studies 
Page 12 of 44
http://www.schizophreniabulletin.oupjournals.org
Schizophrenia Bulletin. For Peer Review Only
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
13 
 
(34), suggesting that NMDA-R hypofunctioning could be associated with an oscillatory 
process in cortical and subcortical regions. In contrast to 30-90 Hz power, beta-band activity 
was strongly reduced, which is in agreement with recent data (35).  
Source-reconstruction of resting-state MEG-activity allowed us to determine the neural 
generators in different frequency ranges. In the 30-90 Hz frequency band, ketamine caused an 
upregulation in subcortical and cortical areas. The largest increases of gamma-band activity 
were observed in the right hippocampus and right/left thalami, followed by parietal, temporal 
and frontal structures (Figure 3). This is in agreement with previous in-vivo studies in rodents 
(9, 27, 36-38), which consistently demonstrated a ketamine-induced increase in spontaneous 
gamma-band activity in cortical and subcortical areas. Decreases in beta-band were localized 
to brain regions that were overall distinct from gamma-band generators. Maximal reductions 
in 13-30 Hz were localized, for example, to the cerebellum, temporal and visual cortex.  
Potential mechanisms for the ketamine-driven upregulation of gamma-band activity are 
increased excitability of pyramidal cells due to reduced activation of GABAergic interneurons 
and a shift in the relative contribution of AMPA and NMDA-R mediated excitatory post 
synaptic potentials (EPSPs) to the drive of interneurons (39). Previous studies have shown 
that NMDA-R hypofunction leads to an increase in firing rate of pyramidal neurons (40). In 
addition, AMPA receptor mediated excitation becomes relatively more preponderant when 
NMDA-Rs are deficient as AMPA-R mediated EPSPs have much faster kinetics than NMDA-
R mediated EPSPs and are more numerous than NMDA-Rs on PV+-interneurons (41). 
Accordingly, reducing the NMDA-R mediated excitatory input on GABAergic interneurons 
increases the ratio of fast over slow EPSPs (39) and this, together with increased activity of 
pyramidal cells, provides favorable conditions for fast oscillations with important implications 
for information processing and network-interactions.  
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Gamma-band oscillations are particularly prominent in superficial layers (layers 2/3) 
(42), the main origin of feedforward projections, and are dependent upon fast, transient 
excitation of fast-spiking interneurons (43). In contrast, beta oscillations are largely found in 
infragranular layers and can be independent of excitatory or inhibitory synaptic transmission 
(44). Current theories suggest that beta-band oscillations are therefore involved in the 
mediation of feedback to lower sensory areas and important for predictive coding processes 
(45). Accordingly, one effect of the NMDA-R hypofunctioning is a possible shift towards 
feed-forward mediated information transmission and/or increase in background activity which 
could interfere with incoming sensory information. As a result, a decrease in signal-to-noise 
in neural circuits occurs (46, 47), which could impact upon the ability to differentiate between 
relevant and irrelevant information, a symptom commonly observed in the early stages of ScZ 
(48). 
This hypothesis is supported by our result of increase functional connectivity (TE) 
between sources, which included the thalamus, hippocampus, parietal and temporal cortices. 
Increased TE-values have to be interpreted as information in one source closely following 
information available in another source (26). Thus, at an information theoretical level, our 
data suggests that MEG-derived generators follow more readily the input they receive, which 
could further amplify the shift towards a higher-frequency regime and thus contribute to a 
breakdown of filtering capabilities with respect to a source's input.  
Interestingly, elevated hippocampal gamma-band activity after ketamine 
administration correlated negatively with positive symptoms as measured with PANSS, 
which contrasts with findings in ScZ-patients indicating an opposite relationship (49). 
One possibility is that elevated hippocampal gamma-band activity during acute 
ketamine administration indexes an initial mechanism to compensate for dysfunctional 
Page 14 of 44
http://www.schizophreniabulletin.oupjournals.org
Schizophrenia Bulletin. For Peer Review Only
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
15 
 
thalamo-cortical sensory transmission through enhanced gating of neuronal responses, a 
process that is least in part mediated by hippocampal interneurons (50), and thus reduce 
the occurrence of psychotic symptoms. 
 
NMDA-R, Gamma-Band Activity, Network Organization and ScZ 
An important question concerns the similarities between the changes in rhythmic activity and 
connectivity patterns resulting from NMDA-R hypofunction in the current study and the 
evidence on abnormal large-scale network-activity in ScZ-patients. As pointed above, 
ketamine and associated NMDA-R hypofunction lead to an upregulation of high-frequency 
activity and increased interactions between nodes of the network.  
Currently, the large majority of studies in patients with ScZ have reported decreases of 
task related gamma band power (51) and connectivity (52, 53). However, a recent study (33) 
showed that background gamma activity is increased during auditory steady-state stimulation 
in SZ which was interpreted as a disruption in E/I-balance parameters. This is furthermore 
supported by preliminary evidence for increased gamma-band in medication-naïve first-
episode ScZ-patients at-rest (11, 54) which has not, however, been confirmed in other studies 
(10, 51, 55).  
Additional evidence supporting the relationship between the role of glutamatergic 
abnormalities and neurophysiological dysfunctions in ScZ comes from several studies that 
have examined functional connectivity in early-stage ScZ with resting-state fMRI. Consistent 
with our finding of increased connectivity in thalamo-cortical circuits, individuals at high risk 
for ScZ and patients with early-course ScZ were characterized by increased connectivity 
which was not present in chronic ScZ-patients (13).   
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The possibility of NMDA-R mediated disinhibition in ScZ at illness-onset is supported 
by our recent data in unmedicated first-episode-ScZ patients which suggests an excessive 
spreading of neural activity as indexed by event-related fields during sensory processing in 
MEG-data (56), as well as by findings suggesting elevated glutamate levels during early 
illness stages which decrease progressively with illness duration (14). Accordingly, these 
findings highlight the possibility of a stage-specific elevation of network-activity and 
organization, which is compatible with a large-scale disinhibition of neural circuits in ScZ.   
Our results of MEG-informed source-localization furthermore are consistent with recent 
data that have highlighted the importance of thalamo-cortical interactions and hippocampal 
circuits in the pathophysiology of ScZ. Several resting-state fMRI studies reported increased 
functional connectivity between thalamus and cortical regions (57-59), albeit some report 
mixed findings (59). In addition, the increase in gamma-band activity in hippocampal sources, 
a brain region with a large number of NMDA-receptor sites (60), is consistent with findings 
highlighting the possible contribution of elevated metabolism as a result of NMDA-R 
hypofunctioning in the early stages of ScZ (61). 
 
Issues for further Research and Limitations  
It should be noted that the interpretation of the physiological effects of ketamine is 
complicated by the fact that, in addition to blocking NMDA-Rs, ketamine also increases the 
systemic levels of dopamine, acetylcholine, and norepinephrine (62). However, more recent 
evidence suggests that the increase in gamma-band activity is mainly due to a specific 
blockade of NMDA receptors containing the NR2A subunit (63).  
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In addition, several brain regions with significant modulation at beta/gamma-band 
frequencies were localized to subcortical areas (thalamus and hippocampus). Albeit MEG 
subcortical source localization remains challenging due to the rapid decay of the 
neuromagnetic field, recent studies have however reported robust signals obtained from 
thalamic and hippocampal sources (64-66), suggesting the potential suitability of MEG to 
detect rhythmic activity from deeper brain regions. 
The important role of the thalamus in the dysregulation of high-frequency oscillations in 
our MEG-data is supported by previous findings showing that the thalamus is centrally 
involved in the regulation of synchronous cortical activity and in the gating of sensory 
information (67). Specifically, there is a large body of evidence showing that gamma-band 
oscillations are robust signature of thalamic activity as indicated by pacemaker function of 
cells in the thalamic reticular nucleus (RT) (68), and pronounced 30-90 Hz oscillations in the 
lateral geniculate nucleus (LGN) (69). Moreover, data from animal model indicate that 
ketamine reduces extracellular GABA levels by acting on NMDA-R PV interneurons (70). In 
particular, GABA release reduction from the RT to other thalamic nuclei, due to inactivation 
of NMDA-R on RT-neurons, would lead to increase firing rate of thalamic relay neurons and 
pathological activation of thalamo-cortical circuits, which could trigger a widespread shift in 
excitability levels (71).  
This evidence is consistent with current findings of thalamic-driven dysregulation of 
connectivity patterns following acute ketamine administration (72). Together, these findings 
highlight an important convergence between pre-clinical findings and MEG-reconstructed 
resting-state networks that identify the thalamus as a core region of ketamine-induced 
network changes. Moreover, NMDA-R blockade by ketamine increases global-based 
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connectivity (12) and increased functional inputs to regions such as the thalamus, frontal lobe 
and occipital cortex, in human fMRI resting-state recordings. 
 
Summary 
The findings of the current study support previous data from invasive electrophysiological 
investigations, which have demonstrated a profound effect of NMDA-hypofunction on 
coordinated high-frequency activity (7, 29). Because some evidence suggests that 
spontaneous gamma-band power may be increased in ScZ-patients, especially at illness-onset 
(73), and because gamma-band activity is constitutive for cognition and normal brain 
functions (1), it is important to further identify the mechanisms through which ketamine leads 
to the upregulation of gamma-band activity. This will require an integration of both targeted 
pharmacological studies in in-vitro and in-vivo preparations as well as further investigations 
of the connectivity and dynamics of large-scale neuronal networks. Further research into the 
mechanisms underlying the effects of NMDA-R on high-frequency activity promises insights 
into the role of beta/gamma-band oscillations for normal brain functions, the pathophysiology 
of ScZ, but also of affective disorders, such as depression, since ketamine has recently been 
demonstrated to act rapidly as an anti-depressant (74). 
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Figure legends 
Figure 1. Average scores on the six different PANSS subscales for the placebo (black) and 
ketamine (gray) conditions. Error bars indicate the s.e.m. (* = p < .05).  
 
Figure 2. Sensor-level analysis. (A) Topoplots representing the average power spectra (fT) of 
gamma (top) and beta (bottom) frequency ranges in the placebo (left) and ketamine (right) 
conditions. (B) Results of the non-parametric cluster-based statistic highlighting sensors 
showing a statistically significant effect for gamma (top) and beta (bottom) frequencies (red: 
ketamine > placebo; blue: colors placebo > ketamine) (* = p < .001).  
 
Figure 3. Source-level analysis. Cluster-based non-parametric statistic highlights statistically 
significant differences between the placebo and ketamine condition across the gamma (left) 
and beta (right) frequency bands (red: ketamine > placebo; blue: placebo > ketamine). 
Gamma-band (30-90 Hz): 1. R-hippocampus [10 -10 -20], 2. R-thalamus [10 -10 10], 3. L-
thalamus [-10 -20 10], 4. L-fusiform gyrus [-40 -10 -30], 5. R-medial frontal cortex [0 40 -
20], 6. L-frontal pole [-20 40 -10], 7. L-superior frontal gyrus [-20 40 40], 8. L-superior 
temporal gyrus [-70 -20 0], 9. L-middle temporal gyrus [-60 0 -30]. Beta-band (13-30 Hz): 1. 
cerebellum [0 -40 -20], 2. L-precuneus [-20 -50 20], 3. R-precuneus [30 -50 10], 4. R-middle 
temporal gyrus [60 -30 -10], 5. L-anterior cingulate [0 20 -10], 6. R-inferior temporal gyrus 
[50 -60 -20], 7. R-visual cortex [30 -90 -10]. 
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Figure 4. Power spetra analysis. (Left) Placebo and ketamine power-spectra as averaged 
across all subjects and calculated considering all MEG sensors (shades indicated the s.e.m.). 
(Right) Relative change (i.e., ((Ketamine power – Placebo power) / Placebo power) * 100) of 
the ketamine power with respect to the placebo power in the gamma-band range.  
 
Figure 5. Transfer entropy (TE) analysis. TE differences between ketamine and placebo 
conditions. Green diamonds indicate MEG sources reactive to ketamine in the gamma band, 
blue circles indicate sources reactive in the beta band (see Figure 3). Arrow colors indicate 
strength of the difference. (A) Uncorrected differences in TE.  (B) Statistically significant 
differences (Bonferroni corrected: p < 2.08*10-4). For illustration purposes we also provide 
the TE differences at a significance threshold of p < 0.0005 uncorrected, for the transfer 
entropy between (C) sources reactive in the beta frequency band, (D) in the gamma frequency 
band, and (E) between beta- and gamma-sources. Legend: FrontalPole-L = left frontal pole, 
MFC = medial frontal cortex, SFG-L = left superior frontal gyrus, ACC = anterior cingulate 
cortex, MTG-L = left middle temporal gyrus, FuG-L = left fusiform gyrus, Th-L= left 
thalamus, Cb = cerebellum, Prec-L = left precuneus, HI-R = right hippocampus, Th-R = right 
thalamus, MTG-R = right medial temporal gyrus,Prec-R = right precuneus,  ITG-R = right 
inferior temporal gyrus, VisualCortex-R = right visual cortex. 
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Figure 1. Average scores on the six different PANSS subscales for the placebo (black) and ketamine (gray) 
conditions. Error bars indicate the s.e.m. (* = p < .05).  
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Sensor-level analysis. (A) Topoplots representing the average power spectra (fT) of gamma (top) and beta 
(bottom) frequency ranges in the placebo (left) and ketamine (right) conditions. (B) Results of the non-
parametric cluster-based statistic highlighting sensors showing a statistically significant effect for gamma 
(top) and beta (bottom) frequencies. Red colors indicate a statistically significant difference in favor of the 
ketamine condition, whereas blue colors indicate a difference in favor of the placebo condition (* = p < 
.001).  
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Power spetra analysis. (A) Placebo and ketamine power-spectra as averaged across all subjects and 
calculated considering all MEG sensors (shades indicated the s.e.m.). (B) Relative change (i.e., ((Ketamine 
power – Placebo power) / Placebo power) * 100) of the ketamine power with respect to the placebo power 
in the gamma-band range.  
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Transfer entropy (TE) analysis. TE differences between ketamine and placebo conditions. Green diamonds 
indicate MEG sources reactive to ketamine in the gamma band, blue circles indicate sources reactive in the 
beta band (see Figure 3). Arrow colors indicate strength of the difference. (A) Uncorrected differences in 
TE.  (B) Statistically significant differences (Bonferroni corrected: p < 2.08*10-4). For illustration purposes 
we also provide the TE differences at a significance threshold of p < 0.0005 uncorrected, for the transfer 
entropy between (C) sources reactive in the beta frequency band, (D) in the gamma frequency band, and 
(E) between beta- and gamma-sources. Legend: FrontalPole-L = left frontal pole, MFC = medial frontal 
cortex, SFG-L = left superior frontal gyrus, ACC = anterior cingulate cortex, MTG-L = left middle temporal 
gyrus, FuG-L = left fusiform gyrus, Th-L= left thalamus, Cb = cerebellum, Prec-L = left precuneus, HI-R = 
right hippocampus, Th-R = right thalamus, MTG-R = right medial temporal gyrus,Prec-R = right 
precuneus,  ITG-R = right inferior temporal gyrus, VisualCortex-R = right visual cortex.  
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Supplementary material 
 
Supplementary Tables 
 
Table S1. PANSS scores for the placebo and the ketamine condition. Indicated are average, 
standard error of the mean (SEM) and t-test statistics. 
 
Placebo 
 
Ketamine 
 
 
Average SEM 
 
Average SEM 
 
t-test 
Negative 8.00 0.60 
 
13.42 1.03 
 
t(11) = -5.03, p <  .001 
Excitement 5.50 0.38 
 
6.92 0.57 
 
t(11) = -2.83, p = .016 
Cognitive 5.50 0.29 
 
10.25 0.72 
 
t(11) = -6.71, p < .001 
Positive 4.08 0.08 
 
6.92 0.48 
 
t(11) = -6.19, p < .001 
Depression 5.67 0.23 
 
10.17 0.44 
 
t(11) = -9.95, p < .001 
Disorganisation 3.08 0.08   5.50 0.65 
 
t(11) = -4.05, p = .002 
Total 35.83 1.00 
 
58.58 2.43 
 
t(11) = -11.10, p < .001 
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Table S2. Labels from the Harvard-Oxford cortical and subcortical structural atlases. Side (R 
= right; L = left), MNI coordinates (X, Y, Z) and t-values of the anatomical regions showing 
statistically significant differences between the placebo and ketamine conditions. All these 
regions showed a bigger gamma-band (30-90 Hz) power in the ketamine compared to the 
placebo condition. 
Label Side X Y Z t-value 
Hippocampus R 10 -10 -20 7.81 
Thalamus R 10 -20 10 6.89 
Thalamus L -10 -20 10 6.67 
Fusiform L -40 -10 -30 5.7 
Medio frontal cortex R 0 40 -20 5.22 
Frontal pole L -20 40 -10 4.91 
Superior Frontal Gyrus L -20 40 40 4.11 
Superior Temporal Gyrus L -70 -20 0 3.48 
Middle Temporal Gyrus L -60 0 -30 2.77 
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Table S3. Labels from the Harvard-Oxford cortical and subcortical structural atlases. Side (R 
= right; L = left), MNI coordinates (X, Y, Z) and t-values of the anatomical regions showing 
statistically significant differences between the placebo and ketamine conditions. All these 
regions showed a reduced beta-band (13-30 Hz) power in the ketamine compared to the 
placebo condition. 
 
Label Side X Y Z t-value 
Cerebellum 
 
0 -40 -20 -5.44 
Precuneus L -20 -50 20 -5.38 
Precuneus R 30 -50 10 -4.68 
Middle Temporal Gyrus R 60 -30 -10 -3.88 
Anterior Cingulate L 0 30 -10 -3.83 
Inferior Tempoal Gyrus R 50 -60 -20 -3.6 
Visual cortex R 30 -90 -10 -2.89 
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Supplementary Methods 
Psychiatric screening 
1. Structured Clinical Interview for DSM-IV (SCID-II) (First, Gibbon, Spitzer, Williams, 
& Benjamin, 1997). 
2. Schizotypal Personality Questionnaire SPQ-G (Raine, 1991). 
3. Symptom Checklist 90 (SCL90) (Derogatis, Lipman, & Covi, 1973). 
 
Psychological assessment 
1. Brief Assessment of Cognition in Schizophrenia battery (BACS) (Keefe et al., 2004).  
2. Edinburgh Handedness Inventory (EHI) (Oldfield, 1971).  
3. Verbal intelligence test (Lehrl, 1989). 
 
MEG analysis – Beamforming 
Power-spectra were source-localized using a beamformer technique in the frequency domain 
with a Dynamical Imaging of Coherent Sources (DICS) beamformer (Gross, 2001). The 
estimation of source power at each voxel was performed by a spatially adaptive filter that was 
divided into a regular 10 mm 3D dipole grid (see supplementary info for more details). To 
calculate the forward model, a realistic volume conductor model (Nolte, 2003) was used and 
the individual head shapes were aligned to the MEG data by means of fiducial markers. 
Finally, the covariance matrix for each individual was computed with a multi-taper Fast-
Fourier transformation and source power was calculated for each grid point.  
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MEG analysis – Labeling clusters of activity 
The source-level cluster-based analysis highlighted clusters of voxels showing increased gamma and 
decreased beta band activity after ketamine administration. T-metrics, as generated by the cluster 
based corrected paired t-test (see source-level analysis in the main manuscript) were used to identify 
“local extrema” within each cluster. Local extrema were localized by considering the voxel with the 
most extreme (most positive for the gamma statistics or negative for the beta statistics) t-value than the 
26 neighboring voxels. As such, we can be confident that the identified extrema are not extensions of 
other clusters. The anatomical label of local maxima has then been localized using the Harvard-Oxford 
cortical atlas and the Harvard-Oxford subcortical atlas. 
 
MEG analysis -Transfer entropy 
To investigate the effects of ketamine on the interactions between sources, we quantified 
changes in information transfer by measuring transfer entropy (TE) functional (Schreiber, 
2000). TE is a model free analysis of functional interactions which measures the amount of 
information from a source arriving at a target that is not contained in the targets history, or 
that can only be decoded together with the targets history (Wibral et al., 2013; Wibral, 
Vicente, & Lindner, 2014). We used the TE estimation algorithms implemented in the 
TRENTOOL toolbox (Lindner, Vicente, Priesemann, & Wibral, 2011; Wollstadt, Martinez-
Zarzuela, Vicente, Diaz-Pernas, & Wibral, in press).  
The TE functional is a specific conditional mutual information I(. : . | . ) between an 
information source X and a target of the information transfer Y: TE(X->Y, δ) = I(Y(t) : X(t- 
δ) | Y(t-1)), where Y(t) is the current sample of the target time series, and where X(t- δ),  Y(t-
1) are past states of source and target time series, respectively (Lindner et al., 2011; Vicente, 
Wibral, Lindner, & Pipa, 2011) and δ is the physical delay of the interaction between source 
and target. This delay can be found via an optimization procedure described in Wibral et al. 
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(Wibral et al., 2013) as: δ = argmaxu TE(X->Y, u), where u is an assumed delay that is 
scanned for a range of values until a maximal TE value is found. Here, TE was computed for 
assumed physical delays u between 4 and 30 ms and the value at the maximal TE was chosen 
for each link, participant and condition.  
Time courses for the TE analysis were reconstructed from the anatomical regions 
showing a statistically significant drug effect (ketamine vs. placebo). Raw data was first 
filtered with a 10 to 150 Hz bandpass, followed by a time-domain linear constrained 
minimum variance (LCMV) beamformer (Van Veen, van Drongelen, Yuchtman, & Suzuki, 
1997), which enabled the reconstruction of source time courses for three orthogonal dipoles in 
the cardinal directions.  
On these three time courses, a principal component analysis was performed in order to 
determine the dominant dipole orientation (i.e., direction with the largest variance), which 
was used for subsequent TE computation. The state space embedding dimension was allowed 
to a range from 2 to 10, and was optimized jointly with the embedding lag parameter τ using 
the Ragwitz criterion (Ragwitz & Kantz, 2002) for each participant. Since differing 
embedding dimensions can bias TE results (Kraskov, Stogbauer, & Grassberger, 2004), while 
a slight over-embedding does not compromise the detection of significant TE (Lindner et al., 
2011), the TE group comparison between the ketamine and placebo conditions was carried 
out considering the maximal embedding dimension of d = 5 across all conditions and 
participants.  
A kernel-based estimator (Kraskov et al., 2004) was used with a fixed mass search for 
next neighbors (n = 4) in the joint space. Faes’ method was implemented to remove residual 
volume conduction effects (Faes, Nollo, & Porta, 2013). Finally, a graph algorithm separated 
direct from indirect interactions by identifying alternative paths with similar sums of delay 
times (Wollstadt et al., in press). Thus, spurious effects due to cascades could be detected and 
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removed. 
In the first step, we assessed global change in TE between all sources at beta/gamma-
frequencies which were characterized by significant modulation through ketamine through 
averaging TE values across all links per participant and conditions. To localize the links, a 
one-sided permutation test for each link was performed and the alpha level was corrected for 
multiple comparison. Given the number of sources (n = 16) and the number of potential 
interactions for each source (n = 15), p was set to 0.05 / 240 (2.08 * 10). In addition, we 
investigated TE-changes separately for interactions between sources in the beta- and gamma-
frequency ranges as well as between the two spectral bands. The alpha level was set to 2.08 * 
10
-4
. 
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